Stay updated on GABA-A Targeting in ASD Clinical Trial
Sign up to get notified when there's something new on the GABA-A Targeting in ASD Clinical Trial page.

Latest updates to the GABA-A Targeting in ASD Clinical Trial page
- CheckyesterdayChange DetectedThe 403 Forbidden message is gone, and the page shows the ClinicalTrials.gov site shell without visible study details.SummaryDifference0.6%

- Check8 days agoChange DetectedA banner announces the NIH website transition and says that some content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check15 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the study record remains behind a 403 error page.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with a generic error page while the site chrome remains visible. This indicates restricted access or a server-side issue preventing the study details from loading.SummaryDifference16%

- Check64 days agoChange DetectedThe page shows a new Revision value, updating from v3.6.5 to v3.6.6. This indicates a minor update to the page or its underlying system, rather than a change to study content.SummaryDifference0.1%

Stay in the know with updates to GABA-A Targeting in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GABA-A Targeting in ASD Clinical Trial page.